12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Clover Health Investments (NASDAQ:CLOV) shares increased by 14.9% to $0.85 during Tuesday’s after-market session. The market value…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday’s pre-market session. The company’s market…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Rallybio (NASDAQ:RLYB) shares moved upwards by 70.5% to $2.78 during Thursday’s regular session. The company’s market cap…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Aclarion (NASDAQ:ACON) stock rose 21.6% to $3.82 during Friday’s after-market session. The company’s market cap stands at…
Recap: Nektar Therapeutics Q3 Earnings
Nektar Therapeutics (NASDAQ:NKTR) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:22 PM. Here’s what…
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell
• CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
A Preview Of Nektar Therapeutics’s Earnings
Nektar Therapeutics (NASDAQ:NKTR) is set to give its latest quarterly earnings report on Tuesday, 2023-11-07. Here’s what investors…
Nektar Presents New Responder Data For Rezpegaldesleukin, A First-In-Class Selective Regulatory T-cell Therapy, In Late-Breaking News Oral Presentation At 2023 EADV Congress
– Dose-Dependent Efficacy Reported Across All Endpoints for REZPEG Demonstrating a Rapid Onset of Action and Continuing Benefit for 36 Weeks After 12-Week Treatment Period –– New Data Presented Show Encouraging
Nektar Therapeutics Announces Two Abstracts Accepted At EADV Congress 2023 For Rezpegaldesleukin, A First-In-Class Selective Regulatory T-cell Therapy
– Phase 1b Safety and Efficacy Data for Rezpegaldesleukin in Moderate to Severe Atopic Dermatitis to be Presented in Late-Breaking Oral Presentation –Nektar Therapeutics (NASDAQ:NKTR) announced today that it will have
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Tango Therapeutics (NASDAQ:TNGX) stock increased by 58.7% to $6.08 during Tuesday’s after-market session. At the close, Tango…